Role of the clinical pharmacist in therapeutic drug monitoring: Mexico's current situation
Academic Area of Pharmacy. Institute of Health Sciences, Autonomous University of the State of Hidalgo. Ex-Hacienda La Concepción Circuit, Km. 1.5, San Agustín Tlaxiaca, Hidalgo. c.p. 42160, Mexico.
Review Article
GSC Biological and Pharmaceutical Sciences, 2023, 22(01), 122-124.
Article DOI: 10.30574/gscbps.2023.22.1.0481
Publication history:
Received on 06 November 2022; revised on 17 December 2022; accepted on 22 December 2022
Abstract:
In developed countries, clinical pharmacists perform various activities depending on the available resources and the health system, and TDM represents one of the fundamental responsibilities, this activity is performed according to the specific pharmacotherapy of the patient, and includes the evolution of the disease, risk factors and treatment goals. In Mexico, the practice of clinical pharmacy, is a relatively new discipline, and there is not yet a specialized service that performs monitoring in which pharmacokinetic concepts are applied. Therefore, it is highly important to promote the integration and participation of hospital clinical pharmacists in the individualization of pharmacological therapies, and to acknowledge the benefits that all this provides.
Keywords:
Pharmacist; Monitoring; Clinical; Pharmacokinetics
Full text article in PDF:
Copyright information:
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0
